Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Liver Neoplasms 2Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 8durvalumab 4Cisplatin 4Gemcitabine 3Ethiodized Oil 3Doxorubicin 3Chemotherapy, Adjuvant 3Bevacizumab 3tremelimumab 2sodium thiosulfate 2phosphomannopentaose sulfate 2Watchful Waiting 2Talaporfin 2Radiofrequency Ablation 2Oxaliplatin 2Nivolumab 2Folfox protocol 2Celecoxib 2Capecitabine 2Analgesia, Patient-Controlled 2seocalcitol 1parecoxib 1nolatrexed 1linifanib 1lenvatinib 1ferumoxides 1ferric carboxymaltose 1contrast agent BR1 1cabozantinib 1brivanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Liver Neoplasms × Talaporfin × Clear all
NCT00440310 2015-08-25

Phase 3 Trial of Litxâ„¢ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Light Sciences Oncology

Phase 3 Completed
483 enrolled 7 charts
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

NCT00355355 2015-01-30

A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Light Sciences Oncology

Phase 3 Completed
208 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡